Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > Incretin Mimetics > Exenatide > Effectivity of Exenatide Therapy > Effectivity after/in combination with Sulonylurea Therapy	Display all items Journal Articles Discussion Articles Comments Discussions Conferences/Workshops Availabilities Grants/Funds Information/News

(Journal Article): Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
 
Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD
 
IN: Diabetes Care 2003; 26(8):2370-2377
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

ABSTRACT: OBJECTIVE: AC2993 (synthetic exendin-4; exenatide) is a peptide that enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon secretion, and slows... Click HERE for details

(Journal Article): Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.
 
Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD
 
IN: Diabetes Care 2004; 27(11):2628-2635
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

ABSTRACT: OBJECTIVE: This study evaluated the ability of the incretin mimetic exenatide (exendin-4) to improve glycemic control in patients with type 2 diabetes failing maximally effective d... Click HERE for details